{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:42:34Z","timestamp":1780454554156,"version":"3.54.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,21]],"date-time":"2015-06-21T00:00:00Z","timestamp":1434844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11912-015-0462-0","type":"journal-article","created":{"date-parts":[[2015,6,20]],"date-time":"2015-06-20T02:33:08Z","timestamp":1434767588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Contemporary Management of Retroperitoneal Soft Tissue Sarcomas"],"prefix":"10.1007","volume":"17","author":[{"given":"Yuliya","family":"Olimpiadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suisui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Matcuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burton L.","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Sener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,21]]},"reference":[{"issue":"7","key":"462_CR1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMra041866","volume":"353","author":"MA Clark","year":"2005","unstructured":"Clark MA et al. Soft-tissue sarcomas in adults. N Engl J Med. 2005;353(7):701\u201311.","journal-title":"N Engl J Med"},{"issue":"4","key":"462_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1308\/003588411X571944","volume":"93","author":"DC Strauss","year":"2011","unstructured":"Strauss DC, Hayes AJ, Thomas JM. Retroperitoneal tumours: review of management. Ann R Coll Surg Engl. 2011;93(4):275\u201380.","journal-title":"Ann R Coll Surg Engl"},{"issue":"2","key":"462_CR3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2353\/jmoldx.2010.090117","volume":"12","author":"R Vreeze de","year":"2010","unstructured":"de Vreeze R et al. Multifocal myxoid liposarcoma\u2014metastasis or second primary tumor?: a molecular biological analysis. J Mol Diagn. 2010;12(2):238\u201343.","journal-title":"J Mol Diagn"},{"issue":"3","key":"462_CR4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ijrobp.2007.07.2337","volume":"70","author":"BA Guadagnolo","year":"2008","unstructured":"Guadagnolo BA et al. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70(3):760\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"462_CR5","doi-asserted-by":"crossref","first-page":"345161","DOI":"10.1155\/2012\/345161","volume":"2012","author":"N Asano","year":"2012","unstructured":"Asano N et al. Metastatic patterns of myxoid\/round cell liposarcoma: a review of a 25-year experience. Sarcoma. 2012;2012:345161.","journal-title":"Sarcoma"},{"issue":"3","key":"462_CR6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/01.MP.0000056983.78547.77","volume":"16","author":"JM Coindre","year":"2003","unstructured":"Coindre JM et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol. 2003;16(3):256\u201362.","journal-title":"Mod Pathol"},{"issue":"3","key":"462_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/107327481101800305","volume":"18","author":"JE Mullinax","year":"2011","unstructured":"Mullinax JE, Zager JS, Gonzalez RJ. Current diagnosis and management of retroperitoneal sarcoma. Cancer Control. 2011;18(3):177\u201387.","journal-title":"Cancer Control"},{"issue":"1","key":"462_CR8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1055-3207(18)30408-3","volume":"5","author":"KA Skinner","year":"1996","unstructured":"Skinner KA, Eilber FR. Soft tissue sarcoma nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am. 1996;5(1):121\u20137.","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"462_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0960-7404(03)00030-6","volume":"12","author":"DG Blazer 3rd","year":"2003","unstructured":"Blazer 3rd DG, Sabel MS, Sondak VK. Is there a role for sentinel lymph node biopsy in the management of sarcoma? Surg Oncol. 2003;12(3):201\u20136.","journal-title":"Surg Oncol"},{"issue":"5","key":"462_CR10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/cncr.24045","volume":"115","author":"G Lahat","year":"2009","unstructured":"Lahat G et al. Computed tomography scan-driven selection of treatment for retroperitoneal liposarcoma histologic subtypes. Cancer. 2009;115(5):1081\u201390.","journal-title":"Cancer"},{"key":"462_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1477-7819-9-143","volume":"9","author":"WW Tseng","year":"2011","unstructured":"Tseng WW et al. Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures. World J Surg Oncol. 2011;9:143.","journal-title":"World J Surg Oncol"},{"key":"462_CR12","doi-asserted-by":"crossref","unstructured":"Orr, S.e.a., Soc Surg Oncol 2015.","DOI":"10.3113\/JSOA.2015.0120"},{"issue":"1","key":"462_CR13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1245\/s10434-014-3965-2","volume":"22","author":"RPSWG Trans-Atlantic","year":"2015","unstructured":"Trans-Atlantic RPSWG. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2015;22(1):256\u201363. Consensus guidelines for management of this disease from diagnosis to treatment are provided from a recent, ongoing multi-institutional collaboration of expert soft tissue sarcoma surgeons.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"462_CR14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1245\/s10434-014-4210-8","volume":"22","author":"N Ikoma","year":"2015","unstructured":"Ikoma N et al. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes. Ann Surg Oncol. 2015;22(4):1068\u201372.","journal-title":"Ann Surg Oncol"},{"key":"462_CR15","volume-title":"Cancer staging manual","author":"AJCC","year":"2010","unstructured":"AJCC. Cancer staging manual. 7th ed. New York: Springer; 2010.","edition":"7"},{"issue":"2","key":"462_CR16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdp298","volume":"21","author":"DA Anaya","year":"2010","unstructured":"Anaya DA et al. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol. 2010;21(2):397\u2013402.","journal-title":"Ann Oncol"},{"issue":"4 Suppl","key":"462_CR17","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.jamcollsurg.2007.06.335","volume":"205","author":"FC Eilber","year":"2007","unstructured":"Eilber FC, Kattan MW. Sarcoma nomogram: validation and a model to evaluate impact of therapy. J Am Coll Surg. 2007;205(4 Suppl):S90\u20135.","journal-title":"J Am Coll Surg"},{"issue":"3","key":"462_CR18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.20.3.791","volume":"20","author":"MW Kattan","year":"2002","unstructured":"Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20(3):791\u20136.","journal-title":"J Clin Oncol"},{"issue":"3","key":"462_CR19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.sla.0000234795.98607.00","volume":"244","author":"KM Dalal","year":"2006","unstructured":"Dalal KM et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244(3):381\u201391.","journal-title":"Ann Surg"},{"key":"462_CR20","unstructured":"STS Soft tissue sarcoma nomogram. http:\/\/www.mskcc.org\/cancer-care\/adult\/soft-tissue-sarcoma\/prediction-tools [cited 2015; MSKCC Nomogram]."},{"issue":"13","key":"462_CR21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1200\/JCO.2012.44.3747","volume":"31","author":"A Gronchi","year":"2013","unstructured":"Gronchi A et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31(13):1649\u201355. Easy to use nomograms, incorporating multiple clinicopathologic factors including tumor histology, are provided which can help predict clinical outcome and counsel patients with retroperitoneal sarcoma.","journal-title":"J Clin Oncol"},{"issue":"5","key":"462_CR22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/bjs.6994","volume":"97","author":"DC Strauss","year":"2010","unstructured":"Strauss DC et al. Surgical management of primary retroperitoneal sarcoma. Br J Surg. 2010;97(5):698\u2013706.","journal-title":"Br J Surg"},{"issue":"9","key":"462_CR23","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1245\/s10434-012-2342-2","volume":"19","author":"S Bonvalot","year":"2012","unstructured":"Bonvalot S et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012;19(9):2981\u201391. This article is particularly relevant for surgeons involved in management of this disease, highlighting the often challenging nature of resection.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"462_CR24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/01.sla.0000250438.04393.a8","volume":"245","author":"JC Gutierrez","year":"2007","unstructured":"Gutierrez JC et al. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg. 2007;245(6):952\u20138.","journal-title":"Ann Surg"},{"issue":"5","key":"462_CR25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF02305556","volume":"4","author":"P Russo","year":"1997","unstructured":"Russo P et al. Nephrectomy during operative management of retroperitoneal sarcoma. Ann Surg Oncol. 1997;4(5):421\u20134.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"462_CR26","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1245\/s10434-011-1742-z","volume":"18","author":"C Mussi","year":"2011","unstructured":"Mussi C et al. Retroperitoneal sarcoma: is it time to change the surgical policy? Ann Surg Oncol. 2011;18(8):2136\u201342.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"462_CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jvs.2006.03.001","volume":"44","author":"MH Schwarzbach","year":"2006","unstructured":"Schwarzbach MH et al. Clinical results of surgery for retroperitoneal sarcoma with major blood vessel involvement. J Vasc Surg. 2006;44(1):46\u201355.","journal-title":"J Vasc Surg"},{"issue":"2","key":"462_CR28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1245\/s10434-011-1954-2","volume":"19","author":"M Fiore","year":"2012","unstructured":"Fiore M et al. Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava. Ann Surg Oncol. 2012;19(2):511\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"462_CR29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/000313480707300504","volume":"73","author":"JR Ouellette","year":"2007","unstructured":"Ouellette JR et al. Tumors at the aortoiliac\/inferior vena cava bifurcation: preoperative, anesthetic, and intraoperative considerations. Am Surg. 2007;73(5):440\u20136.","journal-title":"Am Surg"},{"issue":"7","key":"462_CR30","first-page":"525","volume":"62","author":"SF Sener","year":"1996","unstructured":"Sener SF et al. Hepatic and vena cava resection using cardiopulmonary bypass with hypothermic circulatory arrest. Am Surg. 1996;62(7):525\u20138. discussion 528-9.","journal-title":"Am Surg"},{"issue":"1","key":"462_CR31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1200\/JCO.2008.17.8871","volume":"27","author":"A Gronchi","year":"2009","unstructured":"Gronchi A et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27(1):24\u201330.","journal-title":"J Clin Oncol"},{"issue":"1","key":"462_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1200\/JCO.2008.18.0802","volume":"27","author":"S Bonvalot","year":"2009","unstructured":"Bonvalot S et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"462_CR33","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/annonc\/mdr323","volume":"23","author":"A Gronchi","year":"2012","unstructured":"Gronchi A et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol. 2012;23(4):1067\u201373.","journal-title":"Ann Oncol"},{"issue":"5","key":"462_CR34","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1245\/s10434-014-4130-7","volume":"22","author":"A Gronchi","year":"2015","unstructured":"Gronchi A et al. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Ann Surg Oncol. 2015;22(5):1447\u201354. After extended or compartmental resection, histologic subtype remains an important determinant in the outcome for patients with retroperitoneal sarcoma. An example is the particularly high rate of distant recurrence with leiomyosarcoma.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"462_CR35","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1245\/s10434-011-1746-8","volume":"18","author":"A Gronchi","year":"2011","unstructured":"Gronchi A, Pollock R. Surgery in retroperitoneal soft tissue sarcoma: a call for a consensus between Europe and North America. Ann Surg Oncol. 2011;18(8):2107\u201310.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"462_CR36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1200\/JCO.2008.18.7138","volume":"27","author":"PW Pisters","year":"2009","unstructured":"Pisters PW. Resection of some\u2014but not all\u2014clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol. 2009;27(1):6\u20138.","journal-title":"J Clin Oncol"},{"issue":"11","key":"462_CR37","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00268-010-0721-z","volume":"34","author":"CE Santos","year":"2010","unstructured":"Santos CE et al. Compartment surgery in treatment strategies for retroperitoneal sarcomas: a single-center experience. World J Surg. 2010;34(11):2773\u201381.","journal-title":"World J Surg"},{"key":"462_CR38","doi-asserted-by":"crossref","unstructured":"Pasquali, S., et al., Outcomes following extended surgery for retroperitoneal sarcomas: results from a UK Referral Centre. Ann Surg Oncol, 2015.","DOI":"10.1245\/s10434-015-4380-z"},{"issue":"7","key":"462_CR39","first-page":"641","volume":"27","author":"RE Pollock","year":"2013","unstructured":"Pollock RE. Extended surgery for retroperitoneal sarcoma: too much surgery for some and not enough for others? Con Oncol (Williston Park). 2013;27(7):641\u20132.","journal-title":"Con Oncol (Williston Park)"},{"issue":"7","key":"462_CR40","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1245\/s10434-014-3643-4","volume":"21","author":"WW Tseng","year":"2014","unstructured":"Tseng WW et al. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. 2014;21(7):2136\u201343.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"462_CR41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/bjs.4802","volume":"92","author":"SJ Neuhaus","year":"2005","unstructured":"Neuhaus SJ et al. Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg. 2005;92(2):246\u201352.","journal-title":"Br J Surg"},{"issue":"19","key":"462_CR42","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1002\/cncr.26071","volume":"117","author":"L Voorde Van De","year":"2011","unstructured":"Van De Voorde L et al. Radiotherapy and surgery\u2014an indispensable duo in the treatment of retroperitoneal sarcoma. Cancer. 2011;117(19):4355\u201364.","journal-title":"Cancer"},{"issue":"3","key":"462_CR43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/1097-0142(19940201)73:3<637::AID-CNCR2820730322>3.0.CO;2-Y","volume":"73","author":"RC Doorn van","year":"1994","unstructured":"van Doorn RC et al. Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer. 1994;73(3):637\u201342.","journal-title":"Cancer"},{"issue":"8","key":"462_CR44","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1200\/JCO.1997.15.8.2832","volume":"15","author":"MJ Heslin","year":"1997","unstructured":"Heslin MJ et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol. 1997;15(8):2832\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"462_CR45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/1097-0142(20010715)92:2<359::AID-CNCR1331>3.0.CO;2-Y","volume":"92","author":"E Stoeckle","year":"2001","unstructured":"Stoeckle E et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92(2):359\u201368.","journal-title":"Cancer"},{"issue":"5","key":"462_CR46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jso.21474","volume":"101","author":"S Sampath","year":"2010","unstructured":"Sampath S et al. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol. 2010;101(5):345\u201350.","journal-title":"J Surg Oncol"},{"issue":"4","key":"462_CR47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archsurg.1993.01420160040005","volume":"128","author":"WF Sindelar","year":"1993","unstructured":"Sindelar WF et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg. 1993;128(4):402\u201310.","journal-title":"Arch Surg"},{"issue":"2","key":"462_CR48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0360-3016(01)02595-0","volume":"52","author":"IA Petersen","year":"2002","unstructured":"Petersen IA et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2002;52(2):469\u201375.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"462_CR49","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1245\/ASO.2006.05.035","volume":"13","author":"TM Pawlik","year":"2006","unstructured":"Pawlik TM et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006;13(4):508\u201317.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"462_CR50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jss.2013.05.015","volume":"185","author":"RS Sweeting","year":"2013","unstructured":"Sweeting RS et al. Intraoperative electron radiation therapy as an important treatment modality in retroperitoneal sarcoma. J Surg Res. 2013;185(1):245\u20139.","journal-title":"J Surg Res"},{"issue":"1","key":"462_CR51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2013.10.041","volume":"110","author":"MJ Smith","year":"2014","unstructured":"Smith MJ et al. Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. Radiother Oncol. 2014;110(1):165\u201371.","journal-title":"Radiother Oncol"},{"issue":"8","key":"462_CR52","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/jso.23576","volume":"109","author":"CC Stucky","year":"2014","unstructured":"Stucky CC et al. Excellent local control with preoperative radiation therapy, surgical resection, and intra-operative electron radiation therapy for retroperitoneal sarcoma. J Surg Oncol. 2014;109(8):798\u2013803.","journal-title":"J Surg Oncol"},{"issue":"4","key":"462_CR53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.6004\/jnccn.2014.0053","volume":"12","author":"M Mehren von","year":"2014","unstructured":"von Mehren M et al. Soft tissue sarcoma, version 2.2014. J Natl Compr Canc Net. 2014;12(4):473\u201383.","journal-title":"J Natl Compr Canc Net"},{"issue":"6","key":"462_CR54","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/annonc\/mdr485","volume":"23","author":"A Italiano","year":"2012","unstructured":"Italiano A et al. Advanced well-differentiated\/dedifferentiated liposarcomas: role of chemotherapy and survival. Ann Oncol. 2012;23(6):1601\u20137.","journal-title":"Ann Oncol"},{"key":"462_CR55","doi-asserted-by":"crossref","first-page":"868973","DOI":"10.1155\/2013\/868973","volume":"2013","author":"J Martin-Liberal","year":"2013","unstructured":"Martin-Liberal J et al. Clinical activity and tolerability of a 14-day infusional Ifosfamide schedule in soft-tissue sarcoma. Sarcoma. 2013;2013:868973.","journal-title":"Sarcoma"},{"issue":"1","key":"462_CR56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-3329-4-16","volume":"4","author":"R Sanfilippo","year":"2014","unstructured":"Sanfilippo R et al. High-dose continuous-infusion ifosfamide in advanced well-differentiated\/dedifferentiated liposarcoma. Clin Sarcoma Res. 2014;4(1):16.","journal-title":"Clin Sarcoma Res"},{"issue":"11","key":"462_CR57","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1470-2045(11)70230-3","volume":"12","author":"P Schoffski","year":"2011","unstructured":"Schoffski P et al. Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes. Lancet Oncol. 2011;12(11):1045\u201352.","journal-title":"Lancet Oncol"},{"issue":"11","key":"462_CR58","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1470-2045(12)70474-6","volume":"13","author":"I Ray-Coquard","year":"2012","unstructured":"Ray-Coquard I et al. Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. Lancet Oncol. 2012;13(11):1133\u201340.","journal-title":"Lancet Oncol"},{"issue":"9","key":"462_CR59","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1158\/1078-0432.CCR-11-3203","volume":"18","author":"JJ Luke","year":"2012","unstructured":"Luke JJ et al. The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial. Clin Cancer Res. 2012;18(9):2638\u201347.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"462_CR60","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/bjc.2011.177","volume":"104","author":"GK Schwartz","year":"2011","unstructured":"Schwartz GK et al. Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2\/1). Br J Cancer. 2011;104(12):1862\u20138.","journal-title":"Br J Cancer"},{"issue":"16","key":"462_CR61","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1200\/JCO.2012.46.5476","volume":"31","author":"MA Dickson","year":"2013","unstructured":"Dickson MA et al. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. J Clin Oncol. 2013;31(16):2024\u20138.","journal-title":"J Clin Oncol"},{"issue":"2","key":"462_CR62","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/cancers5020529","volume":"5","author":"WW Tseng","year":"2013","unstructured":"Tseng WW et al. Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial results. Cancers (Basel). 2013;5(2):529\u201349.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"462_CR63","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1200\/JCO.2002.11.050","volume":"20","author":"ML Hensley","year":"2002","unstructured":"Hensley ML et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol. 2002;20(12):2824\u201331.","journal-title":"J Clin Oncol"},{"issue":"19","key":"462_CR64","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1200\/JCO.2006.10.4117","volume":"25","author":"RG Maki","year":"2007","unstructured":"Maki RG et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 2007;25(19):2755\u201363.","journal-title":"J Clin Oncol"},{"issue":"9","key":"462_CR65","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1634\/theoncologist.2011-0467","volume":"17","author":"P Pautier","year":"2012","unstructured":"Pautier P et al. Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). Oncologist. 2012;17(9):1213\u201320.","journal-title":"Oncologist"},{"issue":"9829","key":"462_CR66","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","volume":"379","author":"WT Graaf van der","year":"2012","unstructured":"van der Graaf WT et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2012;379(9829):1879\u201386.","journal-title":"Lancet"},{"issue":"1","key":"462_CR67","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12885-015-1160-x","volume":"15","author":"KH Yoo","year":"2015","unstructured":"Yoo KH et al. Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series. BMC Cancer. 2015;15(1):154.","journal-title":"BMC Cancer"},{"issue":"1","key":"462_CR68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/SLA.0b013e3181928f2f","volume":"249","author":"DA Anaya","year":"2009","unstructured":"Anaya DA et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg. 2009;249(1):137\u201342.","journal-title":"Ann Surg"},{"issue":"5","key":"462_CR69","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jso.23808","volume":"111","author":"C Colombo","year":"2015","unstructured":"Colombo C et al. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma. J Surg Oncol. 2015;111(5):570\u20139. A summary of the published literature for this intervention in patients with multifocal disease, highlighting the need for further studies of efficacy.","journal-title":"J Surg Oncol"},{"issue":"3","key":"462_CR70","first-page":"618","volume":"19","author":"E Halkia","year":"2014","unstructured":"Halkia E, Gavriel S, Spiliotis J. Management of peritoneal surface malignancy: a review of the recent literature. J BUON. 2014;19(3):618\u201326.","journal-title":"J BUON"},{"issue":"38","key":"462_CR71","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.3748\/wjg.v18.i38.5317","volume":"18","author":"I Konigsrainer","year":"2012","unstructured":"Konigsrainer I, Beckert S. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: where are we? World J Gastroenterol. 2012;18(38):5317\u201320.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"462_CR72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.soc.2012.07.001","volume":"21","author":"S Gonzalez-Moreno","year":"2012","unstructured":"Gonzalez-Moreno S, Gonzalez-Bayon L, Ortega-Perez G. Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations. Surg Oncol Clin N Am. 2012;21(4):543\u201357.","journal-title":"Surg Oncol Clin N Am"},{"issue":"9","key":"462_CR73","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/cncr.20192","volume":"100","author":"CR Rossi","year":"2004","unstructured":"Rossi CR et al. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Cancer. 2004;100(9):1943\u201350.","journal-title":"Cancer"},{"issue":"8","key":"462_CR74","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1245\/s10434-007-9463-z","volume":"14","author":"SJ Lim","year":"2007","unstructured":"Lim SJ et al. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol. 2007;14(8):2309\u201318.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"462_CR75","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ejso.2005.04.010","volume":"31","author":"S Bonvalot","year":"2005","unstructured":"Bonvalot S et al. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol. 2005;31(8):917\u201323.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"462_CR76","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1245\/s10434-010-1178-x","volume":"17","author":"D Baratti","year":"2010","unstructured":"Baratti D et al. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol. 2010;17(12):3220\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"462_CR77","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1245\/s10434-013-3269-y","volume":"21","author":"A Hayes-Jordan","year":"2014","unstructured":"Hayes-Jordan A et al. Complete cytoreduction and HIPEC improves survival in desmoplastic small round cell tumor. Ann Surg Oncol. 2014;21(1):220\u20134.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"462_CR78","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jso.23814","volume":"111","author":"WW Tseng","year":"2015","unstructured":"Tseng WW, Amini B, Madewell JE. Follow-up of the soft tissue sarcoma patient. J Surg Oncol. 2015;111(5):641\u20135. Guidelines for appropriate follow-up for soft tissue sarcomas are poorly defined, especially in patients with retroperitoneal disease who are at high risk for recurrence.","journal-title":"J Surg Oncol"},{"issue":"5","key":"462_CR79","doi-asserted-by":"crossref","first-page":"v198","DOI":"10.1093\/annonc\/mdq209","volume":"21","author":"PG Casali","year":"2010","unstructured":"Casali PG, Blay JY, E.C.E.C.P.o. experts. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(5):v198\u2013203.","journal-title":"Ann Oncol"},{"issue":"3","key":"462_CR80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-199809000-00008","volume":"228","author":"JJ Lewis","year":"1998","unstructured":"Lewis JJ et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228(3):355\u201365.","journal-title":"Ann Surg"},{"issue":"1","key":"462_CR81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jso.23463","volume":"109","author":"DE Gyorki","year":"2014","unstructured":"Gyorki DE, Brennan MF. Management of recurrent retroperitoneal sarcoma. J Surg Oncol. 2014;109(1):53\u20139.","journal-title":"J Surg Oncol"},{"issue":"6","key":"462_CR82","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/SLA.0b013e3181b2468b","volume":"250","author":"JO Park","year":"2009","unstructured":"Park JO et al. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule. Ann Surg. 2009;250(6):977\u201382.","journal-title":"Ann Surg"},{"issue":"4","key":"462_CR83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1072-7515(01)01024-9","volume":"193","author":"D Shibata","year":"2001","unstructured":"Shibata D et al. Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? J Am Coll Surg. 2001;193(4):373\u20139.","journal-title":"J Am Coll Surg"},{"issue":"8","key":"462_CR84","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ng.619","volume":"42","author":"J Barretina","year":"2010","unstructured":"Barretina J et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet. 2010;42(8):715\u201321.","journal-title":"Nat Genet"},{"issue":"8","key":"462_CR85","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrc3087","volume":"11","author":"BS Taylor","year":"2011","unstructured":"Taylor BS et al. Advances in sarcoma genomics and new therapeutic targets. Nat Rev Cancer. 2011;11(8):541\u201357.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"462_CR86","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/PAS.0b013e31824f2594","volume":"36","author":"WW Tseng","year":"2012","unstructured":"Tseng WW et al. Lymphocyte composition and distribution in inflammatory, well-differentiated retroperitoneal liposarcoma: clues to a potential adaptive immune response and therapeutic implications. Am J Surg Pathol. 2012;36(6):941\u20134.","journal-title":"Am J Surg Pathol"},{"key":"462_CR87","doi-asserted-by":"crossref","first-page":"547460","DOI":"10.1155\/2015\/547460","volume":"2015","author":"WW Tseng","year":"2015","unstructured":"Tseng WW et al. Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcoma. Sarcoma. 2015;2015:547460. Distinct populations of immune cells are present in the tumor microenvironment which suggest the need for further exploration of immunotherapy in this disease. Importantly, as a preclinical study to assess feasibility of a potential novel therapy, this study focuses on only a specific histologic subtype and is confined to only tumors in the retroperitoneum.","journal-title":"Sarcoma"},{"issue":"4","key":"462_CR88","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27(4):450\u201361.","journal-title":"Cancer Cell"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-015-0462-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-015-0462-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-015-0462-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T16:37:57Z","timestamp":1717951077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-015-0462-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,21]]},"references-count":88,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1007\/s11912-015-0462-0","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,21]]},"article-number":"39"}}